NM_001195553.2(DCX):c.4G>A (p.Glu2Lys) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003560297.2

Allele description [Variation Report for NM_001195553.2(DCX):c.4G>A (p.Glu2Lys)]

NM_001195553.2(DCX):c.4G>A (p.Glu2Lys)

Gene:
DCX:doublecortin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq23
Genomic location:
Preferred name:
NM_001195553.2(DCX):c.4G>A (p.Glu2Lys)
HGVS:
  • NC_000023.11:g.111410395C>T
  • NG_011750.1:g.6784G>A
  • NM_000555.3:c.247G>A
  • NM_001195553.2:c.4G>AMANE SELECT
  • NM_001369370.1:c.4G>A
  • NM_001369371.1:c.4G>A
  • NM_001369372.1:c.4G>A
  • NM_001369373.1:c.4G>A
  • NM_001369374.1:c.4G>A
  • NM_001410715.1:c.4G>A
  • NM_178151.3:c.4G>A
  • NM_178152.3:c.4G>A
  • NM_178153.3:c.4G>A
  • NP_000546.2:p.Glu83Lys
  • NP_001182482.1:p.Glu2Lys
  • NP_001356299.1:p.Glu2Lys
  • NP_001356300.1:p.Glu2Lys
  • NP_001356301.1:p.Glu2Lys
  • NP_001356302.1:p.Glu2Lys
  • NP_001356303.1:p.Glu2Lys
  • NP_001397644.1:p.Glu2Lys
  • NP_835364.1:p.Glu2Lys
  • NP_835365.1:p.Glu2Lys
  • NP_835366.1:p.Glu2Lys
  • NC_000023.10:g.110653623C>T
Protein change:
E2K
Molecular consequence:
  • NM_000555.3:c.247G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195553.2:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369370.1:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369371.1:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369372.1:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369373.1:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369374.1:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001410715.1:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_178151.3:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_178152.3:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_178153.3:c.4G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004298970Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 23, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Familial Lennox-Gastaut syndrome in male siblings with a novel DCX mutation and anterior pachygyria.

Lawrence KM, Mei D, Newton MR, Leventer RJ, Guerrini R, Berkovic SF.

Epilepsia. 2010 Sep;51(9):1902-5. doi: 10.1111/j.1528-1167.2010.02694.x.

PubMed [citation]
PMID:
20726879

Pathogenic E2K mutation of doublecortin X (DCX) alters microtubule stabilisation and actin filament association.

Moslehi M, Ng DCH, Bogoyevitch MA.

Biochem Biophys Res Commun. 2019 Jun 4;513(3):540-545. doi: 10.1016/j.bbrc.2019.04.005. Epub 2019 Apr 9.

PubMed [citation]
PMID:
30979500
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004298970.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This missense change has been observed in individual(s) with DCX-related conditions (PMID: 20726879). It has also been observed to segregate with disease in related individuals. Experimental studies have shown that this missense change affects DCX function (PMID: 30979500). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 2 of the DCX protein (p.Glu2Lys).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024